Schonfeld Strategic Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$315K Buy
52,525
+22,539
+75% +$170K ﹤0.01% 1562
2025
Q4
$215K Sell
29,986
-415,071
-93% -$3.28M ﹤0.01% 1695
2025
Q3
$4.75M Sell
445,057
-39,801
-8% -$391K 0.03% 605
2025
Q2
$4.69M Buy
+484,858
New +$5M 0.03% 585
2025
Q1
Sell
-63,669
Closed -$950K 2423
2024
Q4
$950K Buy
63,669
+42,103
+195% +$686K 0.01% 1146
2024
Q3
$413K Buy
+21,566
New +$447K ﹤0.01% 1521
2023
Q4
Sell
-60,123
Closed -$1.04M 2117
2023
Q3
$1.04M Buy
+60,123
New +$1.25M 0.01% 1008
2023
Q1
Sell
-21,535
Closed -$601K 2489
2022
Q4
$601K Buy
21,535
+12,635
+142% +$323K 0.01% 1432
2022
Q3
$208K Buy
+8,900
New +$269K ﹤0.01% 2310
2022
Q1
Sell
-65,372
Closed -$1.99M 2818
2021
Q4
$1.99M Buy
+65,372
New +$2.13M 0.02% 708

Other funds holding OGN

Schonfeld Strategic Advisors's OGN Position: Q1 2026 in Review

Schonfeld Strategic Advisors increased its Organon & Co (OGN) stake by 75% in Q1 2026, buying an estimated $170K and bringing the position to 52,525 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #1562.

Schonfeld Strategic Advisors first reported a position in OGN in Q4 2021 and has held it in 10 quarters since. The position peaked at $4.75M in Q3 2025. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Schonfeld Strategic Advisors held 52,525 shares of Organon & Co worth $315K as of Q1 2026.
  • Schonfeld Strategic Advisors bought 22,539 Organon & Co shares in Q1 2026, an estimated $170K.
  • Organon & Co made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1562 holding.
  • Schonfeld Strategic Advisors first reported a position in Organon & Co in Q4 2021 and has held it in 10 quarters since.
  • Schonfeld Strategic Advisors's Organon & Co position peaked at $4.75M in Q3 2025.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.